Literature DB >> 2434274

The M2 autoantigen of central nervous system myelin, a glycoprotein present in oligodendrocyte membrane.

R Lebar, C Lubetzki, C Vincent, P Lombrail, J M Boutry.   

Abstract

Autoantibodies with in-vitro demyelinating capacity induced in Hartley and strain 13 guinea pigs with homologous central nervous system (CNS) tissue were used to characterize the target autoantigen M2. Using the Dot Immunobinding technique, M2 was found to be a component of CNS myelin different from basic protein (BP) and from cerebroside. The expression of M2 on oligodendrocytes, cells known to produce CNS myelin, also confirmed that M2 was a component of CNS myelin. Furthermore, the autoradiography of immunoprecipitates formed with radiolabelled guinea pig myelin and analysed in sodium dodecyl sulphate gels showed that M2 was specific to CNS myelin and absent in peripheral nervous system (PNS) myelin. On electrophoresis M2 appeared as two CNS myelin protein bands at the 27 and 54 KD molecular weight levels, distinct from the major protein bands of proteolipid and BP. M2 bands were of glycoprotein nature, as was demonstrated by affinity chromatography of CNS myelin on wheat germ agglutinin (WGA)-Sepharose. A monoclonal antibody induced by BP-free CNS glycoproteins recognized the same bands as anti-M2 serum in guinea pig CNS myelin. This would imply that both M2 bands share common determinants. M2 bands similar to the above in guinea pig were also shown in rat, rabbit and bovine CNS myelin with guinea pig antibodies. The same type of anti-M2 antibodies were induced in rabbit immunized with homologous CNS tissue. Although only a minor component of myelin, M2 is strongly immunogenic compared to BP. M2 antigen could thus be the target of chronic demyelinating processes such as experimental allergic encephalomyelitis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2434274      PMCID: PMC1542532     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

1.  Studies on autoimmune encephalomyelitis in the guinea pig--III. A comparative study of two autoantigens of central nervous system myelin.

Authors:  R Lebar; C Vincent; E Fischer-le Boubennec
Journal:  J Neurochem       Date:  1979-05       Impact factor: 5.372

2.  Multiple sclerosis: serum gamma globulin and demyelination in organ culture.

Authors:  I Grundke-Iqbal; M B Bornstein
Journal:  Neurology       Date:  1980-07       Impact factor: 9.910

3.  Susceptibility of the myelin-associated glycoprotein and basic protein to a neutral protease in highly purified myelin from human and rat brain.

Authors:  S Sato; R H Quarles; R O Brady
Journal:  J Neurochem       Date:  1982-07       Impact factor: 5.372

4.  Tentative identification of a second central nervous system myelin membrane autoantigen (M2) by a biochemical comparison with the basic protein (BP).

Authors:  R Lebar; C Vincent
Journal:  J Neuroimmunol       Date:  1981-12       Impact factor: 3.478

5.  Is Na + ATPase a myelin-associated enzyme?

Authors:  D S Reiss; M B Lees; V S Sapirstein
Journal:  J Neurochem       Date:  1981-04       Impact factor: 5.372

6.  Molecular weight estimation using sodium dodecyl sulfate--pore gradient electrophoresis.

Authors:  J F Poduslo; D Rodbard
Journal:  Anal Biochem       Date:  1980-01-15       Impact factor: 3.365

7.  Demyelination in vitro. Absorption studies demonstrate that galactocerebroside is a major target.

Authors:  C S Raine; A B Johnson; D M Marcus; A Suzuki; M B Bornstein
Journal:  J Neurol Sci       Date:  1981-10       Impact factor: 3.181

8.  Relapsing murine experimental allergic encephalomyelitis induced by myelin basic protein.

Authors:  R B Fritz; C H Chou; D E McFarlin
Journal:  J Immunol       Date:  1983-03       Impact factor: 5.422

9.  In vivo incorporation of [3H]palmitic acid into PO protein, the major intrinsic protein of rat sciatic nerve myelin.

Authors:  H C Agrawal; R E Schmidt; D Agrawal
Journal:  J Biol Chem       Date:  1983-05-25       Impact factor: 5.157

10.  Long term culture of bovine oligodendroglia isolated with a Percoll gradient.

Authors:  R P Lisak; D E Pleasure; D H Silberberg; M C Manning; T Saida
Journal:  Brain Res       Date:  1981-10-26       Impact factor: 3.252

View more
  31 in total

1.  Glycoproteins as targets of autoantibodies in CNS inflammation: MOG and more.

Authors:  Marie Cathrin Mayer; Edgar Meinl
Journal:  Ther Adv Neurol Disord       Date:  2012-05       Impact factor: 6.570

Review 2.  Current understanding of the epidemiologic and clinical characteristics of optic neuritis.

Authors:  Masanori Nakazawa; Hitoshi Ishikawa; Taiji Sakamoto
Journal:  Jpn J Ophthalmol       Date:  2021-05-22       Impact factor: 2.447

Review 3.  The neonatal Fc receptor as therapeutic target in IgG-mediated autoimmune diseases.

Authors:  Alina Sesarman; Gestur Vidarsson; Cassian Sitaru
Journal:  Cell Mol Life Sci       Date:  2010-03-09       Impact factor: 9.261

4.  Oligodendrocyte-specific autoreactive T cells using an alpha/beta T-cell receptor kill their target without self restriction.

Authors:  V Jewtoukoff; R Lebar; M A Bach
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

Review 5.  Immune responses against the myelin/oligodendrocyte glycoprotein in experimental autoimmune demyelination.

Authors:  H C von Büdingen; N Tanuma; P Villoslada; J C Ouallet; S L Hauser; C P Genain
Journal:  J Clin Immunol       Date:  2001-05       Impact factor: 8.317

6.  The autoimmune reactivity to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis is potentially pathogenic: effect of copolymer 1 on MOG-induced disease.

Authors:  A Ben-Nun; I Mendel; R Bakimer; M Fridkis-Hareli; D Teitelbaum; R Arnon; M Sela; N Kerlero de Rosbo
Journal:  J Neurol       Date:  1996-04       Impact factor: 4.849

7.  ProtLID, a Residue-Based Pharmacophore Approach to Identify Cognate Protein Ligands in the Immunoglobulin Superfamily.

Authors:  Eng-Hui Yap; Andras Fiser
Journal:  Structure       Date:  2016-11-23       Impact factor: 5.006

Review 8.  The spectrum of MOG autoantibody-associated demyelinating diseases.

Authors:  Markus Reindl; Franziska Di Pauli; Kevin Rostásy; Thomas Berger
Journal:  Nat Rev Neurol       Date:  2013-06-25       Impact factor: 42.937

9.  Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein.

Authors:  N Kerlero de Rosbo; R Milo; M B Lees; D Burger; C C Bernard; A Ben-Nun
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

Review 10.  B cells in multiple sclerosis.

Authors:  Mark P Burgoon; Donald H Gilden; Gregory P Owens
Journal:  Front Biosci       Date:  2004-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.